Demuris Receives Innovate UK Grant to Develop Novel Ansamycins

Funding the development of new antibiotics for MDR Gram negative infections Newcastle, UK –  December 16, 2020 – Demuris Limited a company focused on the discovery and optimization of novel, bioactive compounds from natural sources today announced it has secured a £90,315 grant from Innovate UK to develop a novel series of Ansamycin analogues. These …

Demuris Receives Innovate UK Grant to Develop Novel Ansamycins Read More »